Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer

Clinical trial NCT03697564 · COMPLETED

Trial details

NCT number: NCT03697564
Sponsor: Hitendra Patel
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Stage IV

Start date: 2019-10-31
Primary completion: 2023-04-12
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.